Acute Leukemias - Republican Scientific Medical Library
Acute Leukemias - Republican Scientific Medical Library
Acute Leukemias - Republican Scientific Medical Library
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
a References 135<br />
4. Gökbuget N, Hoelzer D. (2002) Recent approaches in acute<br />
lymphoblastic leukemia in adults. Rev Clin Exp Hematol 6:114–<br />
141<br />
5. Jones B, Freeman AI, Shuster JJ, et al. (1991) Lower incidence of<br />
meningeal leukemia when prednisone is replaced by dexamethasone<br />
in the treatment of acute lymphocytic leukemia. Med Pediatr<br />
Oncol 19:269–275<br />
6. Bostrom BC, Sensel MR, Sather HN, et al. (2003) Dexamethasone<br />
versus prednisone and daily oral versus weekly intravenous mercaptopurine<br />
for patients with standard-risk acute lymphoblastic<br />
leukemia: A report from the Children’s Cancer Group. Blood<br />
101:3809–3817<br />
7. Todeschini G, Tecchio C, Meneghini V, et al. (1998) Estimated 6year<br />
event-free survival of 55% in 60 consecutive adult acute lymphoblastic<br />
leukemia patients treated with an intensive phase II<br />
protocol on high induction dose of daunorubicin. Leukemia<br />
12:144–148<br />
8. Larson RA.(2004) The US trials in adult acute lymphoblastic leukemia.<br />
Ann Hematol 83(Suppl 1):S127–128<br />
9. Weiss M, Maslak P, Feldman E, et al. (1996) Cytarabine with high<br />
dose mitoxantrone induces rapid complete remissions in adult<br />
acute lymphoblastic leukemia (ALL) without the use of vincristine<br />
or prednisone. J Clin Oncol 14:2480–2485<br />
10. Weiss M (2001) Induction therapyof adult acute lymphocytic leukemia<br />
without the use of vincristine or prednisone. Hem Onc Clin<br />
North Am 15:1–7<br />
11. Larson RA, Dodge RK, Linker CA, et al. (1998) A randomized controlled<br />
trial of filgrastim during remission induction and consolidation<br />
chemotherapy for adults with acute lymphoblastic leukemia:<br />
CALGB study 9111. Blood 92:1556–1564<br />
12. Hoelzer D. (1996) <strong>Acute</strong> lymphoblastic leukemia: Improved outcome<br />
in adult B-cell acute lymphoblastic leukemia. Blood<br />
87:495–508<br />
13. Thomas D, Cortes J, O’Brien S, et al. (1999) Hyper-CVAD program in<br />
Burkitt’s-type adult acute lymphoblastic leukemia. J Clin Oncol<br />
17:2461–2470<br />
14. Thiebault A, Vernant JP, Degos L, et al. (2000) Adult acute lymphocytic<br />
leukemia study testing chemotherapy and autologous and<br />
allogeneic transplantation. A follow-up report of the French protocol<br />
LALA 87. Hem Onc Clin North Am 14:1353–1366<br />
15. Rowe JM, Richards S, Burnett AK, et al. (2001) Favorable results of<br />
allogeneic bone marrow transplantation (BMT) for adults with<br />
Philadelphia (Ph)-chromosome-negative acute lymphoblastic leukemia<br />
(ALL) in first complete remission (CR): Results from the International<br />
ALL Trial (MRC UKALL XII/ECOG E2993). Blood 98:481a<br />
16. Childhood ALL Cooperative Group. (1996) Duration and intensity<br />
of maintenance chemotherapy in acute lymphoblastic leukaemia:<br />
Overview of 42 trials involving 12000 randomized children. Lancet<br />
347:1783–1788<br />
17. Mandelli F, Annino L, Rotoli B (1996) The GIMEMA ALL 0183 trial:<br />
Analysis of 10-year follow-up. Br J Haematol 92:665–672<br />
18. Thomas DA, Kantarjian HM (2001) Lymphoblastic lymphoma.<br />
Hem Onc Clin North Am 15:51–95<br />
19. Thomas DA, Cortes J, O’Brien SM, et al. (2000) Significance of CD20<br />
positivity in de novo acute lymphocytic leukemia (ALL). Blood<br />
96:109a<br />
20. Thomas DA, Cortes J, Giles FJ, et al. (2001) The modified hyper-<br />
CVAD regimen in newly diagnosed adult acute lymphoblastic leukemia<br />
(ALL). Blood 98:590a<br />
21. Szatrowski TP, Dodge RK, Reynolds C, et al. (2003) Lineage specific<br />
treatment of adult patients with acute lymphoblastic leukemia in<br />
first remission with anti-B4-blocked ricin or high-dose cytarabine:<br />
Cancer and Leukemia Group B study 9311. Cancer 97:1471–1480<br />
22. Thomas DA, Faderl S, Cortes J, et al. (2003) Treatment of Philadelphia<br />
chromosome-positive acute lymphocytic leukemia with hyper-CVAD<br />
and imatinib mesylate. Blood [epub ahead of print]<br />
23. Wassmann B, Gökbuget N, Scheuring UJ, et al. (2003) A randomized<br />
multicenter open label phase II study to determine the<br />
safety and efficacy of induction therapy with imatinib (Glivec, formerly<br />
STI571) in comparison with standard induction chemotherapy<br />
in elderly (>55 years) patients with Philadelphia chromosomepositive<br />
(Ph+/BCR-ABL+) acute lymphoblastic leukemia (ALL). Ann<br />
Hematol 82:716–720<br />
24. Gökbuget N, Raff R, Brügge-Mann M, et al. (2004) Risk/MRD<br />
adapted GMALL trials in adult ALL. Ann Hematol 83(Suppl 1):<br />
S129–131